SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-16-741824
Filing Date
2016-10-19
Accepted
2016-10-19 16:59:56
Documents
4
Period of Report
2016-10-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d275720d8k.htm 8-K 18637
2 EX-1.1 d275720dex11.htm EX-1.1 167115
3 EX-5.1 d275720dex51.htm EX-5.1 13746
4 GRAPHIC g275720ex51p1.jpg GRAPHIC 5485
  Complete submission text file 0001193125-16-741824.txt   208499
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-24006 | Film No.: 161942969
SIC: 2834 Pharmaceutical Preparations